• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外用他卡西醇[1α,24(OH)₂D₃]联合日光照射治疗寻常型白癜风的开放性试验:培养的黑素细胞中c-Kit mRNA的上调

Open trial of topical tacalcitol [1 alpha 24(OH)2D3] and solar irradiation for vitiligo vulgaris: upregulation of c-Kit mRNA by cultured melanocytes.

作者信息

Katayama Ichiro, Ashida Miwa, Maeda Aki, Eishi Kumiko, Murota Hiroyuki, Bae Sang Jae

机构信息

Department of Dermatology, Nagasaki University School of Medicine, 1-7-1, Sakamoto, Nagasaki, Japan.

出版信息

Eur J Dermatol. 2003 Jul-Aug;13(4):372-6.

PMID:12948918
Abstract

Vitiligo vulgaris is a common skin disease, however some cases show poor clinical responses to topical steroid ointment or PUVA therapy. Such regimens are generally avoided in the treatment of facial lesions or in pediatric cases because of the undesirable side effects. To confirm the excellent response to combination therapy with topical vitamin D3 ointment and solar irradiation for vitiligo achieved in the initial patients, we conducted an open trial on other patients, most of whom had poor clinical responses to the prior therapies. Fifteen patients (9 men and 6 women) with vitiligo vulgaris were enrolled in this study. Each patient was instructed to sunbathe for 30 minutes within 1 hour after topical application of the tacalcitol [1 alpha 24(OH)(2)D(3)] ointment or cream to the skin lesions every day. Six of 15 patients showed a fair and excellent clinical response to the combination therapy (more than 30% clearance of the vitiligo). The clinical effect was more apparent in patients with a history of less than 5 years of vitiligo (4 of 6 cases) in contrast to those with a history of more than 5 years (2 of 9 cases). In vitro experiments revealed that tacalcitol upregulated the expression of c-Kit mRNA by melanocytes irradiated with linear polarized infrared, UVA or short period solar irradiation. These results suggest that combination therapy with topical vitamin D(3) ointment and solar irradiation can be used as an alternate therapy for vitiligo vulgaris.

摘要

寻常型白癜风是一种常见的皮肤病,然而一些病例对局部用类固醇软膏或补骨脂素加紫外线A(PUVA)疗法的临床反应不佳。由于存在不良副作用,在治疗面部病变或儿科病例时通常避免使用此类疗法。为了证实最初的患者使用局部维生素D3软膏和日光照射联合治疗白癜风取得了良好效果,我们对其他患者进行了一项开放性试验,这些患者大多数对先前的治疗临床反应不佳。15例寻常型白癜风患者(9例男性和6例女性)参与了本研究。指导每位患者每天在局部将他卡西醇[1α,24(OH)₂D₃]软膏或乳膏涂抹于皮肤病变后1小时内日光浴30分钟。15例患者中有6例对联合治疗表现出良好及优秀的临床反应(白癜风清除率超过30%)。与白癜风病史超过5年的患者(9例中的2例)相比,白癜风病史少于5年的患者(6例中的4例)临床效果更明显。体外实验显示,他卡西醇上调了经线性偏振红外线、紫外线A或短时间日光照射的黑素细胞中c-Kit mRNA的表达。这些结果表明,局部维生素D₃软膏和日光照射联合治疗可作为寻常型白癜风的一种替代疗法。

相似文献

1
Open trial of topical tacalcitol [1 alpha 24(OH)2D3] and solar irradiation for vitiligo vulgaris: upregulation of c-Kit mRNA by cultured melanocytes.外用他卡西醇[1α,24(OH)₂D₃]联合日光照射治疗寻常型白癜风的开放性试验:培养的黑素细胞中c-Kit mRNA的上调
Eur J Dermatol. 2003 Jul-Aug;13(4):372-6.
2
First case report of topical tacalcitol for vitiligo repigmentation.外用他卡西醇治疗白癜风复色的首例病例报告。
Pediatr Dermatol. 2008 Mar-Apr;25(2):262-4. doi: 10.1111/j.1525-1470.2008.00648.x.
3
Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.评估外用他卡西醇与日光照射治疗成人非节段型白癜风疗效的随机双盲临床试验
Br J Dermatol. 2009 Feb;160(2):409-14. doi: 10.1111/j.1365-2133.2008.08906.x. Epub 2008 Oct 21.
4
[New aspects on vitamin D3 ointment: vitamin D3 therapy for vitiligo].
Clin Calcium. 2004 Oct;14(10):137-40.
5
Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.外用他卡西醇与308纳米单色准分子光:治疗白癜风的协同组合。
Photodermatol Photoimmunol Photomed. 2006 Dec;22(6):310-4. doi: 10.1111/j.1600-0781.2006.00250.x.
6
Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.他卡西醇治疗寻常型银屑病:西班牙的经验。
J Eur Acad Dermatol Venereol. 2005 Jul;19(4):414-7. doi: 10.1111/j.1468-3083.2005.01099.x.
7
Tacalcitol and narrow-band phototherapy in patients with vitiligo.他卡西醇与窄谱光疗治疗白癜风患者
Clin Exp Dermatol. 2006 Mar;31(2):200-5. doi: 10.1111/j.1365-2230.2005.02037.x.
8
An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.一项比较窄谱 UVB、外用吡美莫司和他克莫司治疗白癜风的开放性随机研究。
Eur J Dermatol. 2009 Nov-Dec;19(6):588-93. doi: 10.1684/ejd.2009.0779. Epub 2009 Aug 4.
9
Profile of clinical efficacy and safety of topical tacalcitol.外用他卡西醇的临床疗效与安全性概况
Acta Biomed. 2005 Apr;76(1):13-9.
10
Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.外用卡泊三醇、倍他米松二丙酸酯及其联合应用治疗局限性白癜风的疗效
J Eur Acad Dermatol Venereol. 2006 Mar;20(3):269-73. doi: 10.1111/j.1468-3083.2006.01420.x.

引用本文的文献

1
Using a Topical Formulation of Vitamin D for the Treatment of Vitiligo: A Systematic Review.采用局部用维生素 D 制剂治疗白癜风:系统评价。
Cells. 2023 Sep 30;12(19):2387. doi: 10.3390/cells12192387.
2
Expression of Epidermal c-Kit+ of Vitiligo Lesions Is Related to Responses to Excimer Laser.白癜风皮损表皮c-Kit+的表达与准分子激光治疗反应相关。
Ann Dermatol. 2016 Aug;28(4):457-63. doi: 10.5021/ad.2016.28.4.457. Epub 2016 Jul 26.
3
Evaluation of acute locoregional toxicity in patients with breast cancer treated with adjuvant radiotherapy in combination with pazopanib.
评估接受辅助放疗联合帕唑帕尼治疗的乳腺癌患者的急性局部区域毒性。
ISRN Oncol. 2012;2012:896202. doi: 10.5402/2012/896202. Epub 2012 Dec 6.
4
The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms.维生素 D 在良性和恶性黑色素细胞肿瘤进展中的潜在作用。
Exp Dermatol. 2010 Oct;19(10):860-4. doi: 10.1111/j.1600-0625.2010.01169.x.